DiaMedica Therapeutics
DMAC
DMAC
43 hedge funds and large institutions have $16.9M invested in DiaMedica Therapeutics in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
68% less capital invested
Capital invested by funds: $52.1M → $16.9M (-$35.2M)
88% less call options, than puts
Call options by funds: $63K | Put options by funds: $534K
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
43
Holding in Top 10
–
Calls
$63K
Puts
$534K
Top Buyers
| 1 | +$401K | |
| 2 | +$355K | |
| 3 | +$210K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$186K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$136K |
Top Sellers
| 1 | -$5.05M | |
| 2 | -$2.97M | |
| 3 | -$2.69M | |
| 4 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$1.69M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$990K |